Correlation Between Trulieve Cannabis and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Trulieve Cannabis and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trulieve Cannabis and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trulieve Cannabis Corp and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Trulieve Cannabis and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trulieve Cannabis with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trulieve Cannabis and Takeda Pharmaceutical.
Diversification Opportunities for Trulieve Cannabis and Takeda Pharmaceutical
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Trulieve and Takeda is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Trulieve Cannabis Corp and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Trulieve Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trulieve Cannabis Corp are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Trulieve Cannabis i.e., Trulieve Cannabis and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Trulieve Cannabis and Takeda Pharmaceutical
Assuming the 90 days horizon Trulieve Cannabis Corp is expected to generate 1.96 times more return on investment than Takeda Pharmaceutical. However, Trulieve Cannabis is 1.96 times more volatile than Takeda Pharmaceutical Co. It trades about 0.09 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.02 per unit of risk. If you would invest 560.00 in Trulieve Cannabis Corp on October 6, 2024 and sell it today you would earn a total of 39.00 from holding Trulieve Cannabis Corp or generate 6.96% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Trulieve Cannabis Corp vs. Takeda Pharmaceutical Co
Performance |
Timeline |
Trulieve Cannabis Corp |
Takeda Pharmaceutical |
Trulieve Cannabis and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Trulieve Cannabis and Takeda Pharmaceutical
The main advantage of trading using opposite Trulieve Cannabis and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trulieve Cannabis position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.Trulieve Cannabis vs. Green Thumb Industries | Trulieve Cannabis vs. Curaleaf Holdings | Trulieve Cannabis vs. Cresco Labs | Trulieve Cannabis vs. GrowGeneration Corp |
Takeda Pharmaceutical vs. Astellas Pharma | Takeda Pharmaceutical vs. Daiichi Sankyo | Takeda Pharmaceutical vs. Chugai Pharmaceutical Co | Takeda Pharmaceutical vs. Bayer AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |